Mercury Labs

  • Market Cap: Micro Cap
  • Industry: Pharmaceuticals & Biotechnology
  • ISIN: INE947G01011
  • NSEID:
  • BSEID: 538964
INR
805.00
33.5 (4.34%)
BSENSE

Jun 03, 03:30 PM

BSE+NSE Vol: 107

  • Price Points
  • Score
  • Mojo Parameters
  • Total Return
  • News and Corporate Actions
  • Key factors
  • Shareholding
  • Financials
  • CompanyCV
stock-recommendationScore
Click here to find our call on this stock
Strong Sell
Sell
Hold
Buy
Strong Buy

Comparison

Company
Score
Quality
Valuation
Financial
Technical
Concord Drugs
Makers Labs.
Vaishali Pharma
Sotac Pharma.
Mercury Labs
Denis Chem Lab
Pharmaids Pharma
Bharat Immunolog
Curis Lifescien.
Zenith Drugs
Onyx Biotec

Why is Mercury Laboratories Ltd ?

1
Weak Long Term Fundamental Strength with a -6.00% CAGR growth in Operating Profits over the last 5 years
  • The company has been able to generate a Return on Equity (avg) of 9.37% signifying low profitability per unit of shareholders funds
2
Flat results in Mar 26
  • PBDIT(Q) Lowest at Rs 2.03 cr.
  • OPERATING PROFIT TO NET SALES (Q) Lowest at 9.93%
  • PBT LESS OI(Q) Lowest at Rs 1.07 cr.
3
Consistent Underperformance against the benchmark over the last 3 years
  • Along with generating -1.66% returns in the last 1 year, the stock has also underperformed BSE500 in each of the last 3 annual periods
stock-recommendationReal-Time Research Report

Verdict Report

How much should you sell?

  1. All quantity irrespective of whether you are making profits or losses

(If sector exposure > 30%, please use optimiser tool to see which are the best stocks to hold in Pharmaceuticals & Biotechnology)

When to re-enter? - We will constantly monitor the company and review our call based on new data

Is Mercury Labs for you?

High Risk, Medium Return

Absolute
Risk Adjusted
Volatility
Mercury Labs
-1.66%
-0.03
51.46%
Sensex
-7.92%
-0.61
13.09%
stock-recommendationQuality
stock-summaryManagement Risk
stock-summaryGrowth
stock-summaryCapital Structure
stock-recommendation
Quality grade scale :

Below Average, Average, Good, Excellent

Quality key factors

Factor
Value
Sales Growth (5y)
2.06%
EBIT Growth (5y)
-6.00%
EBIT to Interest (avg)
5.30
Debt to EBITDA (avg)
0.75
Net Debt to Equity (avg)
0.04
Sales to Capital Employed (avg)
1.33
Tax Ratio
27.11%
Dividend Payout Ratio
7.43%
Pledged Shares
0
Institutional Holding
0
ROCE (avg)
11.60%
ROE (avg)
9.37%
stock-recommendationValuation

Valuation Scorecard stock-summary

stock-recommendation
Valuation grade scale :

Very Risky, Risky, Very Expensive, Expensive, Fair, Attractive, Very Attractive

Valuation Key Factors stock-summary

Factor
Value
P/E Ratio
19
Industry P/E
33
Price to Book Value
1.66
EV to EBIT
17.56
EV to EBITDA
10.93
EV to Capital Employed
1.64
EV to Sales
1.30
PEG Ratio
0.30
Dividend Yield
0.43%
ROCE (Latest)
9.33%
ROE (Latest)
8.80%
Loading Valuation Snapshot...
stock-recommendationTechnicals

Technical key factors

Indicator
Weekly
Monthly
MACD
Mildly Bullish
Bearish
RSI
No Signal
No Signal
Bollinger Bands
Bullish
Sideways
Moving Averages
Mildly Bearish (Daily)
KST
Mildly Bullish
Bearish
Dow Theory
No Trend
No Trend
stock-recommendation Technical Indicator Scale: Bearish, Mildly Bearish, Sideways, Mildly Bullish, Bullish  Turned 
Technical Movement
stock-recommendationFinancial Trend

Financial Trend Scorecard stock-summary

stock-recommendation
Financial Trend scale:

Very Negative, Negative, Flat, Positive, Very Positive, Outstanding

4What is working for the Company
PAT(9M)

Higher at Rs 4.14 Cr

-3What is not working for the Company
PBDIT(Q)

Lowest at Rs 2.03 cr.

OPERATING PROFIT TO NET SALES (Q)

Lowest at 9.93%

PBT LESS OI(Q)

Lowest at Rs 1.07 cr.

Loading Valuation Snapshot...

Here's what is working for Mercury Labs

Profit After Tax (PAT) - Nine Monthly
At Rs 4.14 cr has Grown at 47.95%
Year on Year (YoY)
MOJO Watch
Near term PAT trend is very positive

PAT (Rs Cr)

Profit After Tax (PAT) - Nine Monthly
Higher at Rs 4.14 Cr
than preceding 12 month period ended Mar 2026 of Rs 3.77 cr
MOJO Watch
In the nine month period the company has already crossed sales of the previous twelve months

PAT (Rs Cr)

Here's what is not working for Mercury Labs

Operating Profit (PBDIT) - Quarterly
Lowest at Rs 2.03 cr.
in the last five quarters
MOJO Watch
Near term Operating Profit trend is negative

Operating Profit (Rs Cr)

Operating Profit Margin - Quarterly
Lowest at 9.93%
in the last five quarters
MOJO Watch
Company's efficiency has deteriorated

Operating Profit to Sales

Profit Before Tax less Other Income (PBT) - Quarterly
Lowest at Rs 1.07 cr.
in the last five quarters
MOJO Watch
Near term PBT trend is negative

PBT less Other Income (Rs Cr)